139 related articles for article (PubMed ID: 17641468)
1. Characterization of prion susceptibility in Neuro2a mouse neuroblastoma cell subclones.
Uryu M; Karino A; Kamihara Y; Horiuchi M
Microbiol Immunol; 2007; 51(7):661-9. PubMed ID: 17641468
[TBL] [Abstract][Full Text] [Related]
2. The retention of prion protein in the endoplasmic reticulum prevents N2A cells from proteasome inhibition-induced cytotoxicity.
Fang S; Wang R; Liu H; Zhuang W; Wang Z; Zhang J; Pei L; Liu Y; Su Y
Biochem Biophys Res Commun; 2017 Sep; 491(2):500-507. PubMed ID: 28669732
[TBL] [Abstract][Full Text] [Related]
3. The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines.
Pimpinelli F; Lehmann S; Maridonneau-Parini I
Eur J Neurosci; 2005 Apr; 21(8):2063-72. PubMed ID: 15869502
[TBL] [Abstract][Full Text] [Related]
4. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
5. Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrP
Pankiewicz JE; Sanchez S; Kirshenbaum K; Kascsak RB; Kascsak RJ; Sadowski MJ
Mol Neurobiol; 2019 Mar; 56(3):2073-2091. PubMed ID: 29987703
[TBL] [Abstract][Full Text] [Related]
6. Cell density-dependent increase in the level of protease-resistant prion protein in prion-infected Neuro2a mouse neuroblastoma cells.
Nakamitsu S; Kurokawa A; Yamasaki T; Uryu M; Hasebe R; Horiuchi M
J Gen Virol; 2010 Feb; 91(Pt 2):563-9. PubMed ID: 19812263
[TBL] [Abstract][Full Text] [Related]
7. The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation.
Norstrom EM; Mastrianni JA
J Biol Chem; 2005 Jul; 280(29):27236-43. PubMed ID: 15917252
[TBL] [Abstract][Full Text] [Related]
8. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein.
Schmitt-Ulms G; Legname G; Baldwin MA; Ball HL; Bradon N; Bosque PJ; Crossin KL; Edelman GM; DeArmond SJ; Cohen FE; Prusiner SB
J Mol Biol; 2001 Dec; 314(5):1209-25. PubMed ID: 11743735
[TBL] [Abstract][Full Text] [Related]
9. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles.
Alais S; Simoes S; Baas D; Lehmann S; Raposo G; Darlix JL; Leblanc P
Biol Cell; 2008 Oct; 100(10):603-15. PubMed ID: 18422484
[TBL] [Abstract][Full Text] [Related]
10. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody.
Enari M; Flechsig E; Weissmann C
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9295-9. PubMed ID: 11470893
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells.
Kumar R; McClain D; Young R; Carlson GA
J Gen Virol; 2008 Jun; 89(Pt 6):1525-1532. PubMed ID: 18474570
[TBL] [Abstract][Full Text] [Related]
12. Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation.
Perrier V; Solassol J; Crozet C; Frobert Y; Mourton-Gilles C; Grassi J; Lehmann S
J Neurochem; 2004 Apr; 89(2):454-63. PubMed ID: 15056288
[TBL] [Abstract][Full Text] [Related]
13. Styryl-based and tricyclic compounds as potential anti-prion agents.
Chung E; Prelli F; Dealler S; Lee WS; Chang YT; Wisniewski T
PLoS One; 2011; 6(9):e24844. PubMed ID: 21931860
[TBL] [Abstract][Full Text] [Related]
14. Comparison of abnormal isoform of prion protein in prion-infected cell lines and primary-cultured neurons by PrPSc-specific immunostaining.
Tanaka M; Fujiwara A; Suzuki A; Yamasaki T; Hasebe R; Masujin K; Horiuchi M
J Gen Virol; 2016 Aug; 97(8):2030-2042. PubMed ID: 27267758
[TBL] [Abstract][Full Text] [Related]
15. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein.
Telling GC; Scott M; Mastrianni J; Gabizon R; Torchia M; Cohen FE; DeArmond SJ; Prusiner SB
Cell; 1995 Oct; 83(1):79-90. PubMed ID: 7553876
[TBL] [Abstract][Full Text] [Related]
16. Pathologic prion protein infects cells by lipid-raft dependent macropinocytosis.
Wadia JS; Schaller M; Williamson RA; Dowdy SF
PLoS One; 2008; 3(10):e3314. PubMed ID: 19390657
[TBL] [Abstract][Full Text] [Related]
17. Prion protein complexed to N2a cellular RNAs through its N-terminal domain forms aggregates and is toxic to murine neuroblastoma cells.
Gomes MP; Millen TA; Ferreira PS; e Silva NL; Vieira TC; Almeida MS; Silva JL; Cordeiro Y
J Biol Chem; 2008 Jul; 283(28):19616-25. PubMed ID: 18456654
[TBL] [Abstract][Full Text] [Related]
18. Proteomic consequences of expression and pathological conversion of the prion protein in inducible neuroblastoma N2a cells.
Provansal M; Roche S; Pastore M; Casanova D; Belondrade M; Alais S; Leblanc P; Windl O; Lehmann S
Prion; 2010; 4(4):292-301. PubMed ID: 20930564
[TBL] [Abstract][Full Text] [Related]
19. [Mechanisms of prion transmission].
Sakaguchi S
Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of quality control proteins reduces prion conversion in prion-infected cells.
Thapa S; Abdulrahman B; Abdelaziz DH; Lu L; Ben Aissa M; Schatzl HM
J Biol Chem; 2018 Oct; 293(41):16069-16082. PubMed ID: 30154245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]